Stomach cancer, is linked to drugs used to treat acid reflux, researchers have claimed.
Proton pump inhibitors (PPIs) reduce the amount of acid made by the stomach. These are used to treat acid reflux and stomach cancer ulcers.
Stomach Cancer Study
A study identified an association, between the use of the drug and a higher risk of developing stomach cancer. In the UK, there are more than 50m prescriptions for PPIs every year. These drugs have been linked to many side-effects and an increased risk of death.
Academics in their hard research have been identified some kind of high risk of cancer. In the study they never mention any type of bacteria suspected of fueling the illness’s development.
The risk of developing the disease still rose in line with the dose and duration of PPI treatment.
The Daily Use Of Drugs
Daily use of these drugs can be associated with a higher risk of developing illness. This is more than four times higher than those who used it weekly. If used for more than a year, the risk of developing stomach cancer rose as high as eight times after three or more years.
The use of PPI was compared against another drug. These volunteer participants had been treated with stomach cancer therapy. The therapy combines PPI and antibiotics in order to kill off the H pylori bacteria over a week, between 2003 and 2012.
Scientists then monitored these poor volunteers until they either developed stomach cancer, died or reached the end of the study at the end of 2015.
During this period, 3,271 people took PPIs for an average of almost three years, while 21,729 participants took H2 blockers. A total of 153 people developed stomach cancer. All of these people had long-standing problems with stomach inflammation, the study concludes.